These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21520086)

  • 1. Manufacture and performance evaluation of a stable amorphous complex of an acidic drug molecule and Neusilin.
    Maclean J; Medina C; Daurio D; Alvarez-Nunez F; Jona J; Munson E; Nagapudi K
    J Pharm Sci; 2011 Aug; 100(8):3332-3344. PubMed ID: 21520086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of physically stable amorphous drugs by milling with Neusilin.
    Gupta MK; Vanwert A; Bogner RH
    J Pharm Sci; 2003 Mar; 92(3):536-51. PubMed ID: 12587115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amorphization of Indomethacin by Co-Grinding with Neusilin US2: amorphization kinetics, physical stability and mechanism.
    Bahl D; Bogner RH
    Pharm Res; 2006 Oct; 23(10):2317-25. PubMed ID: 16927179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and Physical Property Optimization of an Amorphous Drug Substance Utilizing a High Surface Area Magnesium Aluminometasilicate (Neusilin(®) US2).
    Allgeier MC; Piper JL; Hinds J; Yates MH; Kolodsick KJ; Meury R; Shaw B; Kulkarni MR; Remick DM
    J Pharm Sci; 2016 Oct; 105(10):3105-3114. PubMed ID: 27492963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of co-grinded mixtures of aceclofenac and neusilin US2 for dissolution enhancement of aceclofenac.
    Vadher AH; Parikh JR; Parikh RH; Solanki AB
    AAPS PharmSciTech; 2009; 10(2):606-14. PubMed ID: 19444620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex effects of drug/silicate ratio, solid-state equivalent pH, and moisture on chemical stability of amorphous quinapril hydrochloride coground with silicates.
    Hailu SA; Bogner RH
    J Pharm Sci; 2011 Apr; 100(4):1503-15. PubMed ID: 24081473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Nanometric Solid Dispersions of Glibenclamide in Neusilin(®) UFL2.
    Censi R; Gigliobianco MR; Dubbini A; Malaj L; Di Martino P
    AAPS PharmSciTech; 2016 Oct; 17(5):1204-12. PubMed ID: 26645108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-microemulsifying tablets prepared by direct compression for improved resveratrol delivery.
    Bolko Seljak K; Ilić IG; Gašperlin M; Zvonar Pobirk A
    Int J Pharm; 2018 Sep; 548(1):263-275. PubMed ID: 29969713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New solid self-microemulsifying systems to enhance dissolution rate of poorly water soluble drugs.
    Mura P; Valleri M; Cirri M; Mennini N
    Pharm Dev Technol; 2012; 17(3):277-84. PubMed ID: 21108583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the ability of various pharmaceutical silicates to amorphize and enhance dissolution of indomethacin upon co-grinding.
    Bahl D; Hudak J; Bogner RH
    Pharm Dev Technol; 2008; 13(3):255-69. PubMed ID: 18484494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of solid dispersion prepared by acid-base interaction into free-flowing and tabletable powder by using Neusilin® US2.
    Shah A; Serajuddin AT
    Int J Pharm; 2015 Apr; 484(1-2):172-80. PubMed ID: 25724137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a mini-tablet of co-grinded prednisone-Neusilin complex for pediatric use.
    Lou H; Liu M; Wang L; Mishra SR; Qu W; Johnson J; Brunson E; Almoazen H
    AAPS PharmSciTech; 2013 Sep; 14(3):950-8. PubMed ID: 23761262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-step continuous extrusion process for the manufacturing of solid dispersions.
    Maniruzzaman M; Nair A; Scoutaris N; Bradley MS; Snowden MJ; Douroumis D
    Int J Pharm; 2015 Dec; 496(1):42-51. PubMed ID: 26403386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the dissolution rate and bioavailability of fenofibrate by a melt-adsorption method using supercritical carbon dioxide.
    Cha KH; Cho KJ; Kim MS; Kim JS; Park HJ; Park J; Cho W; Park JS; Hwang SJ
    Int J Nanomedicine; 2012; 7():5565-75. PubMed ID: 23118538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amorphization of itraconazole by inorganic pharmaceutical excipients: comparison of excipients and processing methods.
    Grobelny P; Kazakevich I; Zhang D; Bogner R
    Pharm Dev Technol; 2015 Jan; 20(1):118-27. PubMed ID: 25312240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous twin-screw granulation for enhancing the dissolution of poorly water soluble drug.
    Maniruzzaman M; Nair A; Renault M; Nandi U; Scoutaris N; Farnish R; Bradley MS; Snowden MJ; Douroumis D
    Int J Pharm; 2015 Dec; 496(1):52-62. PubMed ID: 26387621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tableting properties of silica aerogel and other silicates.
    Hentzschel CM; Alnaief M; Smirnova I; Sakmann A; Leopold CS
    Drug Dev Ind Pharm; 2012 Apr; 38(4):462-7. PubMed ID: 21961994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preformulation studies on solid self-emulsifying systems in powder form containing magnesium aluminometasilicate as porous carrier.
    Krupa A; Szlęk J; Jany BR; Jachowicz R
    AAPS PharmSciTech; 2015 Jun; 16(3):623-35. PubMed ID: 25501870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.